Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 7,062 Reduced 0.07% |
$2,192,044
$310.4 p/Share
|
May 13
2025 |
|
GTLB
|
Brian G Robins
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 11.57% |
$2,386,800
$53.04 p/Share
|
May 13
2025 |
|
HCA
|
Jon M Foster
EVP and COO |
SELL
Open market or private sale
|
Direct | 15,698 Reduced 55.38% |
$5,797,585
$369.32 p/Share
|
May 13
2025 |
|
EVM
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 16,191 Added 0.0% |
$145,557
$8.99 p/Share
|
May 13
2025 |
|
HAIN
|
Celeste A. Clark |
BUY
Open market or private purchase
|
Indirect | 83,000 Added 0.0% |
$148,570
$1.79 p/Share
|
May 13
2025 |
|
MPA
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 35,161 Reduced 0.0% |
$386,771
$11.0 p/Share
|
May 13
2025 |
|
WEST
|
Joe T Ford
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 3.49% |
$73,500
$7.35 p/Share
|
May 13
2025 |
|
HOOD
|
Baiju Bhatt
Director |
SELL
Open market or private sale
|
Indirect | 107,608 Reduced 0.0% |
$6,500,599
$60.41 p/Share
|
May 13
2025 |
|
CDW
|
Frederick J. Kulevich
Officer |
SELL
Open market or private sale
|
Direct | 28,159 Reduced 43.84% |
$5,376,961
$190.95 p/Share
|
May 13
2025 |
|
FICO
|
William J Lansing
President and CEO |
SELL
Open market or private sale
|
Direct | 5,419 Reduced 11.25% |
$11,645,756
$2149.06 p/Share
|
May 13
2025 |
|
FICO
|
William J Lansing
President and CEO |
SELL
Open market or private sale
|
Direct | 592 Reduced 1.39% |
$1,284,734
$2170.16 p/Share
|
May 13
2025 |
|
PTMN
|
David Held
Chief Compliance Officer |
BUY
Open market or private purchase
|
Direct | 320 Added 50.0% |
$3,964
$12.39 p/Share
|
May 13
2025 |
|
AI
|
Thomas M Siebel
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 341,698 Reduced 0.0% |
$8,200,752
$24.0 p/Share
|
May 13
2025 |
|
BGNE
|
Xiaodong Wang
Director |
SELL
Open market or private sale
|
Direct | 41,760 Reduced 100.0% |
$9,356,745
$224.06 p/Share
|
May 13
2025 |
|
PTMN
|
Brandon Satoren
Officer |
BUY
Open market or private purchase
|
Direct | 1,000 Added 49.5% |
$12,430
$12.43 p/Share
|
May 13
2025 |
|
ITOS
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 630,191 Reduced 0.0% |
$5,079,339
$8.06 p/Share
|
May 13
2025 |
|
CTVA
|
Cornel B Fuerer |
SELL
Open market or private sale
|
Direct | 55,242 Reduced 35.21% |
$3,759,770
$68.06 p/Share
|
May 13
2025 |
|
ITOS
|
Mpm Bioventures 2018, L.P. |
SELL
Open market or private sale
|
Indirect | 630,191 Reduced 0.0% |
$5,079,339
$8.06 p/Share
|
May 13
2025 |
|
ITOS
|
Ansbert Gadicke |
SELL
Open market or private sale
|
Indirect | 1,031,931 Reduced 0.0% |
$8,317,363
$8.06 p/Share
|
May 13
2025 |
|
PTMN
|
Edward J. Goldthorpe
President, CEO |
BUY
Open market or private purchase
|
Direct | 1,755 Added 13.22% |
$21,902
$12.48 p/Share
|
May 13
2025 |
|
BFS
|
B Francis Saul Ii
Chairman & CEO |
BUY
Open market or private purchase
|
Direct | 7,179 Added 3.24% |
$241,142
$33.59 p/Share
|
May 13
2025 |
|
PTMN
|
Patrick Schafer
Chief Investment Officer |
BUY
Open market or private purchase
|
Direct | 802 Added 7.58% |
$9,992
$12.46 p/Share
|
May 13
2025 |
|
VIRT
|
John Nixon
Director |
SELL
Open market or private sale
|
Direct | 6,965 Reduced 17.03% |
$298,241
$42.82 p/Share
|
May 13
2025 |
|
ERII
|
David W Moon
President and CEO |
BUY
Open market or private purchase
|
Indirect | 4,200 Added 0.0% |
$51,240
$12.2 p/Share
|
May 13
2025 |
|
TTD
|
David B Wells
Director |
SELL
Open market or private sale
|
Direct | 28,638 Reduced 29.95% |
$2,287,603
$79.88 p/Share
|
May 13
2025 |
|
RBA
|
Andrew John Fesler
Chief People Officer |
SELL
Open market or private sale
|
Direct | 9,075 Reduced 62.13% |
$950,334
$104.72 p/Share
|
May 13
2025 |
|
NCR
|
Laura Sen
Director |
BUY
Open market or private purchase
|
Direct | 22,550 Added 30.17% |
$248,951
$11.04 p/Share
|
May 13
2025 |
|
RBRK
|
Brian K. Mc Carthy
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 4.51% |
$2,000,250
$80.01 p/Share
|
May 13
2025 |
|
RBRK
|
Kiran Kumar Choudary
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 3.4% |
$1,600,800
$80.04 p/Share
|
May 13
2025 |
|
CPRX
|
Gary Ingenito
Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct | 200,000 Reduced 74.38% |
$4,736,000
$23.68 p/Share
|
May 13
2025 |
|
SSNC
|
Michael Jay Zamkow |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 50.05% |
$999,000
$79.92 p/Share
|
May 13
2025 |
|
GREE
|
Christian Mulvihill
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 618 Reduced 0.73% |
$692
$1.12 p/Share
|
May 13
2025 |
|
ORA
|
David Granot
Director |
SELL
Open market or private sale
|
Direct | 950 Reduced 25.94% |
$69,549
$73.21 p/Share
|
May 13
2025 |
|
RIVN
|
Claire Mc Donough
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,937 Reduced 1.15% |
$149,055
$15.0 p/Share
|
May 13
2025 |
|
IIIV
|
Robert Burton Harvey
Director |
SELL
Open market or private sale
|
Indirect | 71,860 Reduced 0.0% |
$1,782,128
$24.8 p/Share
|
May 13
2025 |
|
IIIV
|
John C. Harrison
Director |
SELL
Open market or private sale
|
Indirect | 78,597 Reduced 0.0% |
$1,949,991
$24.81 p/Share
|
May 13
2025 |
|
IIIV
|
David M Wilds
Director |
SELL
Open market or private sale
|
Indirect | 218,400 Reduced 0.0% |
$5,418,504
$24.81 p/Share
|
May 13
2025 |
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 50,743 Reduced 5.61% |
$2,034,286
$40.09 p/Share
|
May 13
2025 |
|
INSM
|
Orlov S Nicole Schaeffer
Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct | 4,999 Reduced 4.14% |
$338,982
$67.81 p/Share
|
May 13
2025 |
|
SEZNL
|
Amin Sabzivand
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 3.25% |
$816,390
$90.71 p/Share
|
May 13
2025 |
|
SEZNL
|
Paul Paradis
Director & President |
SELL
Open market or private sale
|
Indirect | 29,200 Reduced 0.0% |
$2,643,184
$90.52 p/Share
|
May 13
2025 |
|
SEZNL
|
Paul Paradis
Director & President |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 8.64% |
$4,523,000
$90.46 p/Share
|
May 13
2025 |
|
INSM
|
Michael Alexander Smith
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 4,407 Reduced 4.56% |
$298,838
$67.81 p/Share
|
May 13
2025 |
|
CRL
|
Joseph W La Plume
EVP, Corp Strategy & Develop |
SELL
Open market or private sale
|
Direct | 500 Reduced 2.5% |
$72,705
$145.41 p/Share
|
May 13
2025 |
|
KNSA
|
Sanj K Patel
CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct | 2,872 Reduced 2.89% |
$77,630
$27.03 p/Share
|
May 13
2025 |
|
NTCT
|
Michael Szabados
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 20.84% |
$170,775
$22.77 p/Share
|
May 13
2025 |
|
ADES
|
Robert E. Rasmus
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 2,921 Added 0.0% |
$11,684
$4.0 p/Share
|
May 13
2025 |
|
INSM
|
Martina M.D. Flammer
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 8,408 Reduced 8.39% |
$570,146
$67.81 p/Share
|
May 13
2025 |
|
INSM
|
William Lewis
Chair and CEO |
SELL
Open market or private sale
|
Direct | 17,442 Reduced 5.22% |
$1,169,486
$67.05 p/Share
|
May 13
2025 |
|
NXT
|
Howard Wenger
President |
SELL
Open market or private sale
|
Direct | 6,066 Reduced 2.69% |
$333,630
$55.0 p/Share
|
May 13
2025 |